MedPath

Screening for Undiagnosed Type 2 Diabetes in New Classes of Subjects at High Risk

Completed
Conditions
Diabetes Mellitus, Type 2
Registration Number
NCT00520962
Lead Sponsor
IRCCS San Raffaele
Brief Summary

The study aims to evaluate IFG, IGT or unknown type 2 diabetes mellitus in new classes at high risk to develop alterations of glucose metabolism and definition of new pathogenic mechanisms of insulin resistance and atherosclerosis.

The following classes of subjects at high risk will be considered:First degree relatives of patients with type 2 diabetes mellitus, patients with cardiovascular disease and stroke, patients with heart valve disease. age will be \> 30 years, both gender.

Detailed Description

The primary outcome of the study is evaluation of glucose tolerance, insulin sensitivity and insulin secretion before and 2 hours post-glucose load Secondary outcomes are evaluation of endothelial function, of natriuretic peptides and free fatty acids, and inflammation before and 2 hours post-glucose load. New candidate genes will be also evaluated.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
1997
Inclusion Criteria
  • Fasting glucose levels <126 mg/dl
  • Age >30 years
  • Both male and female
Exclusion Criteria
  • Type 1 diabetes
  • Known type 2 diabetes mellitus
  • Pregnancy
  • Impaired kidney and liver function
  • Previous history of malignancies

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Medicine Division, Diabetology, Endocrinology and Metabolic Disease Unit, IRCCS San Raffaele

🇮🇹

Milan, Italy

© Copyright 2025. All Rights Reserved by MedPath